Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 725 of 3173 entries
View as:

Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT06393465 Org: User:
Start: 06/15/24 End: 06/30/25 Due: 06/30/26

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

Phase: N/A Priority: Normal
NCT ID: NCT04428411 Org: User:
Start: 07/05/20 End: 08/30/20 Due: 08/30/21

A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product

Phase: N/A Priority: Normal
NCT ID: NCT01906125 Org: User:
Start: 09/30/13 End: 01/31/14 Due: 01/31/15

Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.

Phase: N/A Priority: Normal
NCT ID: NCT02793232 Org: User:
Start: 06/13/16 End: 01/05/17 Due: 01/05/18

A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01571362 Org: User:
Start: 06/30/12 End: 06/30/13 Due: 06/30/14

A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin

Phase: N/A Priority: Normal
NCT ID: NCT03386279 Org: User:
Start: 07/02/18 End: 10/01/18 Due: 10/01/19

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02219048 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza

Phase: N/A Priority: Normal
NCT ID: NCT05227001 Org: User:
Start: 04/28/22 End: 08/04/23 Due: 08/04/24

A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.

Phase: N/A Priority: Normal
NCT ID: NCT06085924 Org: User:
Start: 11/14/23 End: 08/14/24 Due: 08/14/25

A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00357825 Org: User:
Start: 08/31/06 End: 03/31/07 Due: 03/31/08

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

Phase: N/A Priority: Normal
NCT ID: NCT05011513 Org: User:
Start: 08/25/21 End: 07/25/22 Due: 07/25/23

A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865

Phase: N/A Priority: Normal
NCT ID: NCT02138500 Org: User:
Start: 05/31/14 End: 08/31/14 Due: 08/31/15

Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

Phase: N/A Priority: Normal
NCT ID: NCT00108433 Org: User:
Start: 09/30/05 End: 09/30/06 Due: 09/30/07

[S,S]-Reboxetine Add-On Trial

Phase: N/A Priority: Normal
NCT ID: NCT00334685 Org: User:
Start: 08/22/06 End: 10/11/07 Due: 10/11/08

A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)

Phase: N/A Priority: Normal
NCT ID: NCT00075218 Org: User:
Start: 12/31/03 End: 05/31/08 Due: 05/31/09

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Phase: N/A Priority: Normal
NCT ID: NCT00503529 Org: User:
Start: 07/31/07 End: 09/30/10 Due: 09/30/11

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

Phase: N/A Priority: Normal
NCT ID: NCT00658008 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06033612 Org: User:
Start: 11/12/21 End: 07/27/22 Due: 07/27/23

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Phase: N/A Priority: Normal
NCT ID: NCT04071158 Org: User:
Start: 10/01/19 End: 12/11/19 Due: 12/11/20

Korean Regulatory Post Marketing Surveillance for Somavert

Phase: N/A Priority: Normal
NCT ID: NCT05131100 Org: User:
Start: 07/13/22 End: 09/15/26 Due: 09/15/27

Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

Phase: N/A Priority: Normal
NCT ID: NCT00003775 Org: User:
Start: 12/31/98 End: 05/31/06 Due: 05/31/07

A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04230213 Org: User:
Start: 01/13/20 End: 06/22/21 Due: 06/22/22

A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

Phase: N/A Priority: Normal
NCT ID: NCT03000439 Org: User:
Start: 05/10/18 End: 03/27/24 Due: 03/27/25

A Study Comparing Amounts of Tafamidis In The Blood Without Food

Phase: N/A Priority: Normal
NCT ID: NCT02697864 Org: User:
Start: 04/30/16 End: 06/30/16 Due: 06/30/17

Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair

Phase: N/A Priority: Normal
NCT ID: NCT00936559 Org: User:
Start: 09/30/10 End: 02/29/12 Due: 02/28/13